In 4 months we added 5.4 milllion in achieving one milestone, added another 5 million in a drug approval, added 8 million in stock price for srpt but were down close to a $1. And were not even including the 126 million in cash position. Come on truly a work of art having some knucklehead manipulate the stock cause they have the money. And as I speak we just added another 200k because srpt just added .50. Do you know how many companies need to sell additional shares just to finance there drug going though trials that is above astx ? many many many.